BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 38163834)

  • 1. Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy".
    Putz F; Bock M; Schmitt D; Bert C; Blanck O; Ruge MI; Hattingen E; Karger CP; Fietkau R; Grigo J; Schmidt MA; Bäuerle T; Wittig A
    Strahlenther Onkol; 2024 Jan; 200(1):1-18. PubMed ID: 38163834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
    Guckenberger M; Baus WW; Blanck O; Combs SE; Debus J; Engenhart-Cabillic R; Gauer T; Grosu AL; Schmitt D; Tanadini-Lang S; Moustakis C
    Strahlenther Onkol; 2020 May; 196(5):417-420. PubMed ID: 32211940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy.
    Schmitt D; Blanck O; Gauer T; Fix MK; Brunner TB; Fleckenstein J; Loutfi-Krauss B; Manser P; Werner R; Wilhelm ML; Baus WW; Moustakis C
    Strahlenther Onkol; 2020 May; 196(5):421-443. PubMed ID: 32211939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfalls.
    Putz F; Mengling V; Perrin R; Masitho S; Weissmann T; Rösch J; Bäuerle T; Janka R; Cavallaro A; Uder M; Amarteifio P; Doussin S; Schmidt MA; Dörfler A; Semrau S; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 May; 196(5):444-456. PubMed ID: 32206842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
    Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
    Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.
    Moustakis C; Blanck O; Ebrahimi Tazehmahalleh F; Ka Heng Chan M; Ernst I; Krieger T; Duma MN; Oechsner M; Ganswindt U; Heinz C; Alheit H; Blank H; Nestle U; Wiehle R; Kornhuber C; Ostheimer C; Petersen C; Pollul G; Baus W; Altenstein G; Beckers E; Jurianz K; Sterzing F; Kretschmer M; Seegenschmiedt H; Maass T; Droege S; Wolf U; Schoeffler J; Haverkamp U; Eich HT; Guckenberger M
    Strahlenther Onkol; 2017 Oct; 193(10):780-790. PubMed ID: 28567503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.
    Sterzing F; Brunner TB; Ernst I; Baus WW; Greve B; Herfarth K; Guckenberger M
    Strahlenther Onkol; 2014 Oct; 190(10):872-81. PubMed ID: 25091267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
    Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
    Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.
    Wilke L; Andratschke N; Blanck O; Brunner TB; Combs SE; Grosu AL; Moustakis C; Schmitt D; Baus WW; Guckenberger M
    Strahlenther Onkol; 2019 Mar; 195(3):193-198. PubMed ID: 30649567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma].
    Hamm K; Herold HU; Surber G; Rosahl S
    HNO; 2017 May; 65(5):434-442. PubMed ID: 28078405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-Related Geometric Distortions in Stereotactic Radiotherapy Treatment Planning: Evaluation and Dosimetric Impact.
    Pappas EP; Alshanqity M; Moutsatsos A; Lababidi H; Alsafi K; Georgiou K; Karaiskos P; Georgiou E
    Technol Cancer Res Treat; 2017 Dec; 16(6):1120-1129. PubMed ID: 29332453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To frame or not to frame? Cone-beam CT-based analysis of head immobilization devices specific to linac-based stereotactic radiosurgery and radiotherapy.
    Babic S; Lee Y; Ruschin M; Lochray F; Lightstone A; Atenafu E; Phan N; Mainprize T; Tsao M; Soliman H; Sahgal A
    J Appl Clin Med Phys; 2018 Mar; 19(2):111-120. PubMed ID: 29363282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image fusion for stereotactic radiotherapy and radiosurgery treatment planning.
    Kooy HM; van Herk M; Barnes PD; Alexander E; Dunbar SF; Tarbell NJ; Mulkern RV; Holupka EJ; Loeffler JS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1229-34. PubMed ID: 8175410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
    Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
    Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-based treatment planning for brain stereotactic radiosurgery: Dosimetric validation of a learning-based pseudo-CT generation method.
    Wang T; Manohar N; Lei Y; Dhabaan A; Shu HK; Liu T; Curran WJ; Yang X
    Med Dosim; 2019 Autumn; 44(3):199-204. PubMed ID: 30115539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.
    Chan AW; Black P; Ojemann RG; Barker FG; Kooy HM; Lopes VV; McKenna MJ; Shrieve DC; Martuza RL; Loeffler JS
    Neurosurgery; 2005 Jul; 57(1):60-70; discussion 60-70. PubMed ID: 15987541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiotherapy of brain metastases: clinical impact of three-dimensional SPACE imaging for 3T-MRI-based treatment planning.
    Welzel T; El Shafie RA; V Nettelbladt B; Bernhardt D; Rieken S; Debus J
    Strahlenther Onkol; 2022 Oct; 198(10):926-933. PubMed ID: 35976408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial.
    Zabel-du Bois A; Milker-Zabel S; Henzel M; Popp W; Debus J; Sack H; Engenhart-Cabillic R
    Strahlenther Onkol; 2012 Sep; 188(9):769-76. PubMed ID: 22847518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery planning of vestibular schwannomas: Is MRI at 3 Tesla geometrically accurate?
    Schmidt MA; Wells EJ; Davison K; Riddell AM; Welsh L; Saran F
    Med Phys; 2017 Feb; 44(2):375-381. PubMed ID: 28019663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.